Chattanooga Research Site Helping To Study Investigational Celiac Disease Treatment

CeliAction Study Enrolling Patients At ClinSearch

Tuesday, November 12, 2013

ClinSearch Tuesday announced it is participating in a global study to help advance celiac disease research. The CeliAction Study (https://www.celiactionstudy.com/) is a clinical research study that is designed to assess whether an investigational drug can improve the damage in the lining of the intestine caused by traces of gluten contaminating a gluten-free diet. The study will also evaluate whether the investigational drug improves any symptoms of celiac disease.  ClinSearch has begun enrolling participants at its site in Chattanooga.  

Celiac disease is an inherited autoimmune disorder that affects susceptible people of all ages. When people with celiac disease eat certain gluten-containing foods, their immune systems react to the gluten and damages the lining of the small intestine, interfering with their ability to absorb nutrients from the food. Gluten is a plant protein found in foods like wheat, rye and barley.  The immune reaction to gluten triggers uncomfortable symptoms including abdominal pain, diarrhea, joint pain, skin rash and mouth sores. Undiagnosed and untreated, celiac disease can lead to the development of other autoimmune disorders, as well as osteoporosis, infertility, neurological conditions and in rare cases, cancer.

About one in every 100 people in the United States has celiac disease.  The only available option for people with this disease is to attempt try to follow a strict gluten-free diet. 

"While many of those with celiac disease experience some improvement in symptoms after committing to a gluten-free diet, even the slightest exposure to gluten can trigger symptoms and further damage the lining of their small intestines,” said Daniel Leffler, MD, MS, director of Clinical Research at Beth Israel Deaconess Medical Center Celiac Center. “Celiac disease is more than just an upset stomach; the ongoing autoimmune reaction can result in an inability to properly absorb nutrition, which in turn, can lead to long-term serious health issues such as osteoporosis and anemia. Other long-tern complications of the disease, though rare, can include intestinal cancers and lymphoma.” 

“There is a real need to develop new treatment options for people with celiac disease,” said Richard Krause, M.D., site principal investigator, ClinSearch. “That’s why we are so excited to let people here in Chattanooga know that if they have been diagnosed with celiac disease and are struggling to manage their celiac disease with only a gluten-free diet, they may qualify to participate in our research program. While participation is not right for everyone, we have a real opportunity here to advance celiac disease research.”

The CeliAction study is looking for diagnosed celiac patients who are at least 18 years old, on a gluten-free diet for at least 11 months and have experienced at least one moderate to severe symptom of celiac disease in the past month. Qualified participants who are randomized will not be intentionally exposed to gluten during the study and must maintain their gluten-free diet throughout the duration of the study. 

Qualified participants who are randomized into the 12-week long CeliAction Study will receive access to study-related care from qualified physicians. Qualified participants may also receive compensation for time and travel.

The research study is sponsored by Alvine Pharmaceuticals. For more information, visit www.CeliActionStudy.com or call 1-855-3333-ACT



Free Bariatric Seminars Hosted By CHI Memorial Metabolic And Bariatric Care

Jaime Ponce, M.D. and CHI Memorial Metabolic and Bariatric Care will host free seminars in May on surgical weight loss options. The seminars will be held at CHI Memorial Metabolic and Bariatric Care, 7405 Shallowford Road, Suite 160. "Obesity can be devastating to a person’s health and self-esteem. These educational seminars are designed to help you better understand bariatric ... (click for more)

Dr. Charles Woods Named Chair Of Pediatrics, Chief Medical Officer At Children’s Hospital Of Erlanger

Dr. Charles Woods, former chairman of the Department of Pediatrics with the University of Louisville College of Medicine, has been named chairman of the Department of Pediatrics at the University of Tennessee College of Medicine Chattanooga and chief medical officer of the Children’s Hospital at Erlanger. The announcement was made jointly by Dr. Bruce Shack, dean of the University ... (click for more)

Jury Clears Juvenile Judge Philyaw Of Discrimination Charge In Dismissal Of Openly Gay Magistrate

A federal jury deliberated about an hour on Tuesday afternoon before ruling in favor of Juvenile Court Judge Rob Philyaw, who had been sued by an openly gay magistrate that he dismissed. Judge Travis McDonough had dismissed the other two defendants - Court Administrator Sam Mairs and Hamilton County - from the case at the close of the proof. Judge Philyaw said, "I thank the ... (click for more)

Attorney Elliott Says City Council Action On Mountain Creek Zoning Case "Highly Irregular And Highly Illegal"

The City Council on Tuesday night took action on a Mountain Creek zoning case, though attorney Sam Elliott said it was "highly irregular and highly illegal." The council voted 7-2 to instruct the city attorney to file a new zoning case on a section of the former Quarry golf course against the wishes of the owner of the property and the developer who plans to buy it. Attorney ... (click for more)

Why Can't Someone Unstop The Water Buildup Problem At The I-24 Cummings Highway Exit? - And Response

Exit 174 on westbound Interstate 24 is closed again as is the westbound entrance ramp. Cummings Highway is shut as well. I inquired at TDOT on Dec. 28, 2015, why this continues to happen. The engineer’s response was that the drain from ground west of the interstate runs under private land and cover over it has caused that pipe to collapse. Obviously flow still goes through, ... (click for more)

Roy Exum: ‘We’ll Lose The Senate!’

A guy who I admire and respect wrote me yesterday. He had just read my story defending Bob Corker for honoring “The Code” due to his true friendship with Phil Bredesen. He is also no stranger to my vivid dislike of the Republican choice to replace Corker in the Senate. Marsha Blackburn is no match against Bredesen on any tier and it is clearly the Republican Party itself that has ... (click for more)